Global Human Growth Hormone hGH
Market Report
2025
The Human Growth Hormone hGH market size is projected to grow from USD 3.88 Billion in the year 2021 to USD 8.67 Billion by 2029 at a CAGR of 6.69% from 2021-2029.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Human Growth Hormone hGH Market Report 2025.
The Human Growth Hormone hGH market size is projected to grow from USD 3.88 Billion in the year 2021 to USD 8.67 Billion by 2029 at a CAGR of 6.69% from 2021-2029.
Growth Hormone Deficiency was the largest segment with 36.25% share of total revenue generated in 2021.
In Terms of Revenue, Intramuscular was the Leading segment with 38.97% Share of total Human Growth Hormone hGH Market in 2021.
In Terms of Revenue, The Hospital Pharmacy was the Leading segment with 41.23% Share of total Human Growth Hormone hGH Market in 2021.
North America was the dominated region with 32.15% of total revenue market share in 2021.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Human Growth Hormone hGH Market Sales Revenue | $ 3.88 Billion | 121212 | 121212 | 6.69% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
Market Split by Route of Administration |
|
Market Split by Distribution Channel |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Human Growth Hormone hGH industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Human Growth Hormone hGH Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
hGH is a substance produced by pituitary gland, which spurs growth among children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth. Besides, it allows proper regulation of sugar and fat metabolism and to some extent heart function as well. Synthetically produced hGH has been developed in 1985 and approved by FDA strictly for specific uses.Adults who have a growth hormone deficiency might be prescribed synthetic hGH by their health care provider. This may occur by a benign tumor on the pituitary gland (pituitary adenoma) or by treatment of an adenoma with surgery or radiotherapy. It is been approved by FDA in the treatment of adults with AIDS- or HIV-related growth hormone deficiency that causes irregular distribution of body fat.However, prolong use of hGH might cause a number of side effects for healthy adults, including: type 2 diabetes, joint and muscle pain, rise in insulin resistance, edema, and name a few.
Growth disorder refers to constitutional delay of growth and pubertal development. A child tends to be shorter than average and to enter puberty later than average, while growing at a normal rate. It is mainly affected because of disrupted hormones. It may be the result of injuries to the pituitary gland or brain. Cushing syndrome can impair height but cause weight gain. Precocious puberty is a condition caused by hormone problems. Owing to various factors, short stature is a common paediatric problem. According to WHO, 149 million children under 5 were estimated to be stunted in year 2020. Children with growth hormone deficiency have abnormality in the natural process of pituitary gland. This results in lack of hGH production in body. In such conditions, synthetic human growth hormone is injected to stave off some of the changes linked to aging, such as decreased muscle and bone mass. Hence, surge in the prevalence of growth disorder in children propel the growth of hGH market.Moreover, vigorous product pipeline and active R&D activities for the development of novel growth hormone therapies are expected to be the major factors driving the market for human growth hormones.For instance, Ascendis Pharma has TransCon hGH in clinical trial process for pediatric and adult growth hormone deficiency in Japan, China and other parts of world. Thus, surging R&D activities will create lucrative opportunities in the growth of hGH market.
Recent research trends of human growth hormone (hGH) are divided into improved first-generation products, long-acting second-generation products, and biosimilar products.The primary trend of hGH is to improve the first generation hGH by upgrading the injection device needed for administration for the convenience of patients. The second trend is developing a long-acting second generation hGH by extending the half-life of the first-generation hGH.The second-generation hGH development using Glycosylation, PEGylation, and Fc-fusion is actively being studied and is expected to be commercially available in the near future. The final trend is developing a biosimilar (similar biological product) product. The concept of the development of “biosimilar” is similar to that of the “generic products” of chemical drugs by supplying expensive biotherapeutics at a lower price for patients to give better treatment opportunities.
We have various report editions of Human Growth Hormone hGH Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
Lumos' oral growth hormone drug falls short of Novo's injectable incumbent at interim analysis
Texas-based Lumos is developing the drug candidate LUM-201, a small molecule that Merck previously studied in patients with growth hormone deficiency, in the belief it promotes secretion of the hormone from the pituitary gland. However, the oral treatment of Lumos Pharma has failed to match up to Novo Nordisk’s injected drug Norditropin at the interim analysis of a phase 2 trial. But with growth in the Norditropin arm exceeding expectations, Lumos has pinned the blame on baseline imbalances.
Novo Nordisk’s somapacitan shows favourable profile in GHD trial
The company has reported positive data from the Phase II REAL 3 clinical trial of somapacitan in children with growth hormone deficiency (GHD). The drug has demonstrated safety, efficacy and tolerability comparable to that of once-daily Norditropin (somatropin) after one year. An improved efficacy has been reported for the highest somapacitan dose.
Genentech has received approval for hGH in USA:
Genentech has received approval to market its recombinant human growth hormone product, Nutropin, for the treatment of short stature caused by GH deficiency in the USA. The approval came on the same day that Eli Lilly's period of orphan drug exclusivity for its Humatrope (somatropin) product ran out.
Nutropin was Genentech's second hGH product in the market - its Protropin version, first launched in 1985, is slightly different in structure.
FDA snubs new growth deficiency med somatrogon, developed by Pfizer and partner OPKO Health:
The FDA has rejected somatrogon, a potential treatment for pediatric growth hormone deficiency. Pfizer lost a first-mover advantage for a long-acting pediatric growth hormone deficiency drug in the U.S. when Ascendis Pharma won an FDA go-ahead in August for Skytrofa, which is also given once every week.
Top Companies Market Share in Human Growth Hormone hGH Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Asia Pacific is anticipated to witness highest CAGR in Human Growth Hormone hGH market during the forecast period:
North America is predicted to make up the greatest portion of the market due to excellent reimbursement conditions, an established healthcare infrastructure, considerable government initiatives, and rising healthcare awareness. The presence of major firms in the area also facilitates greater access to innovative medications, which benefits the North American market. Several major companies with U.S. headquarters, including Pfizer, Inc., Eli Lilly and Company, and Genentech, Inc., provide a variety of human GH medicines in the area.However, Asia-Pacific is expected to register the highest CAGR in terms of revenue during the forecast period, owing to the increase in population and rise in awareness amongst the population.
The current report Scope analyzes Human Growth Hormone hGH Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Human Growth Hormone hGH Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Human Growth Hormone hGH Industry growth. Human Growth Hormone hGH market has been segmented with the help of its Type, Application Route of Administration, and others. Human Growth Hormone hGH market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.
Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments
Type of Human Growth Hormone hGH analyzed in this report are as follows:
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Human Growth Hormone hGH Industry. Request a Free Sample PDF!
Synthetic human growth hormone was developed in 1985, but FDA approved the usage of drug only for specific disorders. For instance, it is commonly used in children for treating short stature of unknown cause as well as poor growth due to a number of medical causes.Further, awareness regarding turner syndrome is rising and thus hGH use in this syndrome is creating opportunities for the growth of market.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Injecting hGH directly into muscles results in quick absorption of hormone in bloodstream. Because there is more blood in muscle tissue. Moreover, holding capacity of muscle tissue is relatively more than skin tissue. Hence hGH is widely given intramuscular route of administration.
By Distribution Channel:
Hospital pharmacy dominate the market in terms of distribution of hGH. This can be attributed owing to large population visit hospitals for the treatment of growth disorders.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Recombinant Human Growth Hormone rhGH, Human Growth Hormone rhGH |
Application | Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Small for Gestational Age |
Route of Administration | Intravenous, Intramuscular, Subcutaneous, Oral |
Distribution Channel | Hospital Pharmacy, Retail Pharmacy, Clinics, Online Pharmacy |
List of Competitors | Eli Lilly and Company, Ferring Holding SA, Genentech, Merck Co., Novo Nordisk, Pfizer, Sandoz International GmbH, Ipsen |
This chapter will help you gain GLOBAL Market Analysis of Human Growth Hormone hGH. Further deep in this chapter, you will be able to review Global Human Growth Hormone hGH Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Human Growth Hormone hGH. Further deep in this chapter, you will be able to review North America Human Growth Hormone hGH Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Human Growth Hormone hGH. Further deep in this chapter, you will be able to review Europe Human Growth Hormone hGH Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Human Growth Hormone hGH. Further deep in this chapter, you will be able to review Asia Pacific Human Growth Hormone hGH Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Human Growth Hormone hGH. Further deep in this chapter, you will be able to review South America Human Growth Hormone hGH Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Human Growth Hormone hGH. Further deep in this chapter, you will be able to review Middle East Human Growth Hormone hGH Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Human Growth Hormone hGH. Further deep in this chapter, you will be able to review Middle East Human Growth Hormone hGH Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Human Growth Hormone hGH. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Route of Administration Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Distribution Channel Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Human Growth Hormone hGH market
Chapter 14 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 15 Research Methodology and Sources
Why Recombinant Human Growth Hormone rhGH have a significant impact on Human Growth Hormone hGH market? |
What are the key factors affecting the Recombinant Human Growth Hormone rhGH and Human Growth Hormone rhGH of Human Growth Hormone hGH Market? |
What is the CAGR/Growth Rate of Growth Hormone Deficiency during the forecast period? |
By type, which segment accounted for largest share of the global Human Growth Hormone hGH Market? |
Which region is expected to dominate the global Human Growth Hormone hGH Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|